These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27215221)

  • 1. Facioscapulohumeral Dystrophy.
    Wang LH; Tawil R
    Curr Neurol Neurosci Rep; 2016 Jul; 16(7):66. PubMed ID: 27215221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facioscapulohumeral Muscular Dystrophy.
    DeSimone AM; Pakula A; Lek A; Emerson CP
    Compr Physiol; 2017 Sep; 7(4):1229-1279. PubMed ID: 28915324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facioscapulohumeral muscular dystrophy.
    Tawil R
    Neurotherapeutics; 2008 Oct; 5(4):601-6. PubMed ID: 19019312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model.
    Bosnakovski D; Chan SSK; Recht OO; Hartweck LM; Gustafson CJ; Athman LL; Lowe DA; Kyba M
    Nat Commun; 2017 Sep; 8(1):550. PubMed ID: 28916757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facioscapulohumeral dystrophy.
    Pandya S; King WM; Tawil R
    Phys Ther; 2008 Jan; 88(1):105-13. PubMed ID: 17986494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facioscapulohumeral dystrophy: activating an early embryonic transcriptional program in human skeletal muscle.
    Campbell AE; Belleville AE; Resnick R; Shadle SC; Tapscott SJ
    Hum Mol Genet; 2018 Aug; 27(R2):R153-R162. PubMed ID: 29718206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facioscapulohumeral muscular dystrophy.
    van der Maarel SM; Frants RR; Padberg GW
    Biochim Biophys Acta; 2007 Feb; 1772(2):186-94. PubMed ID: 16837171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies.
    Statland JM; Shah B; Henderson D; Van Der Maarel S; Tapscott SJ; Tawil R
    Muscle Nerve; 2015 Oct; 52(4):521-6. PubMed ID: 25704033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for the management of facioscapulohumeral muscular dystrophy in 2011.
    Attarian S; Salort-Campana E; Nguyen K; Behin A; Andoni Urtizberea J
    Rev Neurol (Paris); 2012 Dec; 168(12):910-8. PubMed ID: 22551571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facioscapulohumeral muscular dystrophy.
    Fitzsimons RB
    Curr Opin Neurol; 1999 Oct; 12(5):501-11. PubMed ID: 10590886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction.
    Turki A; Hayot M; Carnac G; Pillard F; Passerieux E; Bommart S; Raynaud de Mauverger E; Hugon G; Pincemail J; Pietri S; Lambert K; Belayew A; Vassetzky Y; Juntas Morales R; Mercier J; Laoudj-Chenivesse D
    Free Radic Biol Med; 2012 Sep; 53(5):1068-79. PubMed ID: 22796148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facioscapulohumeral Muscular Dystrophies.
    Wagner KR
    Continuum (Minneap Minn); 2019 Dec; 25(6):1662-1681. PubMed ID: 31794465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Studies on the Genetic and Clinical Diagnosis of Facioscapulohumeral Muscular Dystrophy.
    Hamel J; Tawil R
    Neurol Clin; 2020 Aug; 38(3):529-540. PubMed ID: 32703466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of fascioscapulohumeral muscular dystrophy misdiagnosed as Becker's muscular dystrophy for 20 years.
    Ramos VF; Thaisetthawatkul P
    Age Ageing; 2012 Mar; 41(2):273-4. PubMed ID: 21795275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscular dystrophy in a patient with multiple sclerosis. Another "double-trouble"?
    Parissis D; Ioannidis P; Bakirtzis C; Grigoriadis N; Karacostas D
    Mult Scler Relat Disord; 2015 Jul; 4(4):342-4. PubMed ID: 26195054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD).
    Goselink RJ; Schreuder TH; Mul K; Voermans NC; Pelsma M; de Groot IJ; van Alfen N; Franck B; Theelen T; Lemmers RJ; Mah JK; van der Maarel SM; van Engelen BG; Erasmus CE
    BMC Neurol; 2016 Aug; 16():138. PubMed ID: 27530735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging preclinical animal models for FSHD.
    Lek A; Rahimov F; Jones PL; Kunkel LM
    Trends Mol Med; 2015 May; 21(5):295-306. PubMed ID: 25801126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early onset facioscapulohumeral dystrophy - a systematic review using individual patient data.
    Goselink RJM; Voermans NC; Okkersen K; Brouwer OF; Padberg GW; Nikolic A; Tupler R; Dorobek M; Mah JK; van Engelen BGM; Schreuder THA; Erasmus CE
    Neuromuscul Disord; 2017 Dec; 27(12):1077-1083. PubMed ID: 29102079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
    Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Approaches in Facioscapulohumeral Muscular Dystrophy.
    Cohen J; DeSimone A; Lek M; Lek A
    Trends Mol Med; 2021 Feb; 27(2):123-137. PubMed ID: 33092966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.